Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial Legionnaires' disease

Journal of Clinical Microbiology

Volumn 41, Issue 2, 2003, Pages 838-840

  Helbig, Jürgen H ^a   Uldum, Søren A ^b   Bernander, Sverker ^c   Lück, Paul Christian ^a   Wewalka, Günther ^d   Abraham, Bill ^e   Gaia, Valeria ^f   Harrison, Timothy G ^g  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b STATENS SERUM INSTITUT   (Denmark)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d Bundesstaatl Baktiol Serologische   (Austria)

^e STOBHILL HOSPITAL   (United Kingdom)

^f Istituto Batteriosierologico Cantonale   (Switzerland)

^g CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; BACTERIUM CULTURE; COMMUNITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; HOSPITAL INFECTION; HUMAN; IMMUNOASSAY; LEGIONNAIRE DISEASE; PRIORITY JOURNAL; TRAVEL;

ANTIGENS, BACTERIAL; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; HUMANS; IMMUNOENZYME TECHNIQUES; LEGIONNAIRES' DISEASE; SENSITIVITY AND SPECIFICITY; TRAVEL;

BACTERIA (MICROORGANISMS); LEGIONELLA; NEGIBACTERIA;

EID: 12244271452     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.2.838-840.2003     Document Type: Article

References (18)

1. Benson, R. F., P. W. Tang, and B. S. Fields. 2000. Evaluation of the Binax and Biotest urinary antigen kits for the detection of Legionnaires' disease due to multiple serogroups and species of Legionella. J. Clin. Microbiol. 38:2763-2765.
2. Craven, D. E., and K. A. Steger. 1997. Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist. Infect. Control Hosp. Epidemiol. 18:783-795.
3. Dennis, P. J., and J. V. Lee. 1988. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J. Appl. Bacteriol. 65:135-141.
4. Dournon, E. W., F. Bibb, P. Rjagopalan, N. Desplaces, and R. M. McKinney. 1988. Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains. J. Infect. Dis. 157:496-501.
5. Ehret, W., B. U. von Specht, and G. Ruckdeschel. 1986. Discrimination between clinical and environmental strains of Legionella pneumophila by a monoclonal antibody. Isr. J. Med. Sci. 22:715-723.
6. Fields, B. S., R. F. Benson, and R. E. Besser. 2002. Legionella and Legionnaires' disease: 25 years of investigation. Clin. Microbiol. Rev. 15:506-526.
7. Formica, N., M. Yates, M. Beers, J. Carne, G. Hogg, N. Ryan, and G. Tallis. 2001. The impact of diagnosis by Legionella urinary antigen test on the epidemiology and outcomes of Legionnaires' disease. Epidemiol. Infect. 127:275-280.
8. Helbig, J. H., J. B. Kurtz, M. Castellani-Pastoris, C. Pelaz, and P. C. Lück. 1997. Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups. J. Clin. Microbiol. 35:2841-2845.
9. Helbig, J. H., S. A. Uldum, P. C. Lück, and T. G. Harrison. 2001. Detection of Legionella pneumophila antigen in urine samples using the BinaxNOW immunochromatographic assay and comparison with both Binax Legionella Urinary Enzyme Immunoassay (EIA) and Biotest Legionella Urin Antigen EIA. J. Med. Microbiol. 50:509-516.
10. Helbig, J. H., S. A. Uldum, P. C. Lück, and T. G. Harrison. 2002. Detection of Legionella pneumophila antigen in urine samples: recognition of serogroups and monoclonal subgroups, p. 204-206. In R. Marre et al. (ed.), Legionella. ASM Press. Washington, D.C.
11. Helbig, J. H., P. C. Lück, Y. A. Knirel, W. Witzleb, and U. Zähringer. 1995. Molecular characterization of a virulence-associated epitope on the lipopolysaccharide of Legionella pneumophila serogroup 1. Epidemiol. Infect. 115:71-78.
12. Horn, J. 2002. Comparison of non-serogroup 1 detection by Biotest and Binax Legionella urinary antigen enzyme immunoassays, p. 207-210. In R. Marre et al. (ed.), Legionella. ASM Press, Washington, D.C.
13. Joly, J. R., R. M. McKinney, O. J. Tobin, W. F. Bibb, I. D. Watkins, and D. Ramsay. 1986. Development of a standardized subgrouping scheme for Legionella pneumophila serogroup 1 using monoclonal antibodies. J. Clin. Microbiol. 23:768-771.
14. Joseph, C. 2002. Surveillance of Legionnaires' disease in Europe, p. 311-317. In R. Marre et al. (ed.), Legionella. ASM Press, Washington, D.C.
15. Joseph, C. A., J. M. Watson, T. G. Harrison, and C. L. R. Bartlett. 1994. Nosocomial Legionnaires' disease in England and Wales, 1980-92. Epidemiol. Infect. 112:329-345.
16. Plouffe, J. F., T. M. File, R. F. Breiman, B. A. Hackman, S. J. Salstrom, B. J. Marston, and B. S. Fields. 1995. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Clin. Infect. Dis. 20:1286-1291.
17. Vergis, E. N., E. Abkas, and V. L. Yu. 2000. Legionella as a cause of severe pneumonia. Semin. Respir. Crit. Care Med. 21:295-304.
18. Zähringer, U., Y. A. Knirel, B. Lindner, J. H. Helbig, A. Sonesson, R. Marre, and E. T. Rietschel. 1995. The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog. Clin. Biol. Res. 392:113-139.